Poland’s Kamil Majchrzak has been provisionally suspended by the International Tennis Integrity Agency (ITIA) for failing a drug take a look at.
The participant who’s ranked No.77 on the earth mentioned that he didn’t knowingly take a banned substance and that the news was “the biggest shock.”
Majchrzak, who gained the Challenger Tour occasion in Busan, South Korea in October and reached the semi-finals of an ATP 250 occasion in Pune, India earlier this 12 months, didn’t present additional particulars concerning the banned substance.
The ITIA mentioned on Friday that Majchrzak had supplied samples from tournaments at Sofia in September and Japan and Seoul in October which had been discovered to include three banned substances (SARM S-22, LGD-4033 and PPARd agonists).
“I have some incredibly sad and difficult news to share with everyone. I have tested positive in anti-doping controls during October and November 2022,” Majchrzak wrote in a submit on Instagram.
“Firstly, I have never, ever, knowingly taken any banned substance. At this moment I have no idea what has happened and this is the biggest shock.
“I’ve began essentially the most troublesome struggle of my life — the struggle to show my innocence and to return to the game I like.”
The ITIA said the player can request that his B samples are analysed to see if they confirm the A sample findings.
“While provisionally suspended, he’s ineligible to compete in or attend any sanctioned tennis occasions organised by the governing our bodies of the game,” the ITIA mentioned.
